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Introduction
Four-week quit rates, both self-report and carbon monoxide (CO)-verified, have been used to evaluate
the effectiveness of stop smoking services since their inception in 1999. Although it does not take
into account a number of important factors that affect success rates (e.g. level of dependence, age,
socio-economic status etc), this measurement does allow for a crude comparison between stop smoking
services and within services over time.
The main purpose of this briefing, however, is to review the evidence on the effectiveness of four-week
quit rates as a predictor of long-term abstinence versus measurement of quit rates for longer periods
following the quit date. This briefing does not cover the evidence on extending behavioural support
and treatment to smokers beyond four weeks, which is covered in a separate NCSCT briefing.
The current standard within the stop smoking services for the assessment of success rates is CO-verified
four-week quit rates.1 A 4-week quitter is defined as someone who reports abstinence between weeks
two and four from the target quit date, verified by an expired air CO concentration of less than 10ppm
(parts per million).2 By this standard the average success rates of the services in England is 36%.3
Although the CO threshold and the exact length of follow-up remain a matter of some debate,4
(guidelines for the evaluation of smoking cessation interventions in clinical trials recommend assessing
smoking status at a minimum of six months)5;6 there are a number of reasons why the current standard
constitutes the primary measure of service success.
Decreasing the CO threshold does not improve accuracy
Evidence suggests that reducing the CO threshold below 10ppm does not significantly affect validated
quit rates until the threshold goes very low (below 3ppm), at which point there is evidence that this
starts to misclassify genuine abstainers.7 The only exception to the 10ppm threshold is for pregnant
smokers where in order to avoid missing any women who smoke, given the heightened importance
of stopping smoking at this time, a lower cut-off point of 4ppm is recommended.8–10
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Longer follow-ups result in greater drop-outs
and are impracticable
Figure 1 provides estimates of drop out rates (lost-to-follow-up) from a number of research studies
examining smoking cessation interventions, including the stop smoking services. The law of attrition
suggests that increasing the length of follow-up will increase the rate of drop out.11 Indeed, drop out
is already substantial at four weeks but doubles over longer follow-up periods.
Figure 1: Loss to follow-up with different treatments
Note: Data come from representative primary research of smoking cessation treatments;14–19
SSS = Stop smoking services (behavioural support + medication); NRT = Nicotine replacement therapy
Although in smoking cessation research, drop outs are considered to be smokers,4 introducing such
assumptions can result in an underestimation of treatment effects and imprecision, especially when
the number of lost-to-follow-up is large.12 Missing data should, therefore, be minimised if we want
to gain a true picture of the effectiveness of stop smoking services. Shorter follow-up (e.g. at four
weeks) represents a better way to keep drop-out rates low; maintaining adequate longer term
follow-up rates is impractical as it is resource-intensive and incurs costs that can otherwise be used
for service delivery.13
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Long-term relapse rates are well established
Years of research have accumulated a wealth of studies which have informed the shape of the relapse
curve in smoking cessation which is typically downward sloping and negatively accelerated, common
to most survival curves and behaviours.20;21
As shown in Figure 2A, and as evidenced by analysis of long-term outcomes of smoking cessation
treatment,22 the trajectory of the relapse curve is typically the same for assisted or unassisted a quit
attempts. Figure 2B provides the typical path of unaided quit attempts which, since it is approximate
to aided quit attempts in its shape, can be used to predict long-term abstinence rates that are based
on relatively short follow-up. Consequently, it can be assumed that the current 36% (CO-validated)
smoking cessation success rate at 4 weeks will result in approximately 9% long-term quitters among
stop smoking service clients23 compared with around 3–4% among those who quit unaided.
This is in contrast with the need for longer follow-ups in clinical trials of new treatments and interventions.
In such circumstances the typical shape of the relapse curve is not yet known and may differ from the
classic shape, therefore longer follow-ups are required to increase accuracy.24
aData come from Zhu et al25;
bData approximately based on Hughes et al26 and West and Stapleton27
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Figure 2A: Survival function for aided and
unaided quit attemptsa
Figure 2B: Relapse and abstinence during
unaided quit attemptsb
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Four week quit rates provide adequate reliability
and validity
As shown in Figure 2B, most smokers relapse within the first couple of days of a serious quit attempt and
the prognosis for permanent cessation improves five-fold in the first four weeks.27 Indeed, only at four
weeks follow-up does the weekly risk of relapse drop below the likelihood of being a long-term abstainer.
Based on this information, it is possible to deduce sensitivity (the true positive rate) and specificity (the
true negative rate) at different follow-up points. Sensitivity is high across all follow-up assessments
insofar as people who will become long-term abstinent will be abstinent from early on and counted
as such. The vast majority of lapses turn into relapses and few people recover from an early lapse to
become abstinent long-term (see NCSCT Briefing: The Not-a-Puff Rule). Specificity, by contrast, differs
across follow-up points as the risk of relapse decreases rapidly, resulting in many relapsers not being
identified early on but most being correctly identified by four weeks with a specificity above 90% and
little improvement thereafter.
Lastly, it is possible to evaluate whether four week quit rates provide a reasonably accurate measurement
of long-term cessation by comparing predictors of both short-term (four-week) and longer-term (one
year) cessation in relation to known predictors of quit success.28 The assumption is that if both short and
longer-term follow-ups produce similar predictors which correspond to known predictors of success that
they measure the same underlying construct, i.e. long-term cessation. As can be seen in Table 1, there
is a large overlap in the predictors of successful abstinence at both short and longer-term follow-up,
including the two most reliable predictors of quit success: nicotine dependence and socioeconomic status.29
Table 1: Association of predictors of quit success with abstinence at 4 and 52 weeks.
aData come from Judge et al16; bData come from Ferguson et al15
Note: ? indicates direction is unclear, – indicates absence of significant association
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4-week 52 week
Predictors abstinence
a abstinenceb
                                                                                                                 Direction of significant association
Low socio-economic status
High nicotine dependence
Older age
Women
Motivation to quit
Poor health status
Smoke for pleasure
–
?
?
Conclusion
Four-week CO-validated quit rates represent a reliable and valid indicator of smoking cessation which,
based on a large body of research, can be used to predict long-term abstinence rates. Taken together
with only modest increases in accuracy for longer follow-ups, but with associated disadvantages in
terms of the feasibility and costs of such long-term assessments, the current standard for measuring
the abstinence of clients using stop smoking services provides a good balance between accuracy and
practicability.
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